Learn More
Invitrogen™ Infliximab Chimeric Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA541776
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Infliximab with the brand name of Remicade, is a chimeric monoclonal IgG1 antibody. It binds to TNF-alpha, which is a key proinflammatory cytokine involved in chronic inflammatory diseases. Infliximab functions as TNF-alpha blocker to disrupt the interaction of TNF-alpha with its receptors.
Specifications
| Infliximab Chimeric | |
| Recombinant Monoclonal | |
| Unconjugated | |
| Remicade; TA-650 | |
| Human TNF-alpha. | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid | |
| Chemical |
| ELISA, SDS-Page | |
| 1.2 mg/mL | |
| PBS with no preservative; pH 7.4 | |
| Human | |
| Protein A/G | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 κ |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.